This HTML5 document contains 75 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n12http://en.wikipedia.org/wiki/Dana%E2%80%93
n13http://en.wikipedia.org/wiki/Grapefruit%E2%80%93
n11http://en.wikipedia.org/wiki/List_of_drugs:_Im%E2%80%93
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://en.wikipedia.org/wiki/Category:
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
clgohttp://caligraph.org/ontology/
n4http://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbrhttp://dbpedia.org/resource/
clgrhttp://caligraph.org/resource/
Subject Item
clgr:Nicholas_Lydon
clgo:knownFor
clgr:Imatinib
Subject Item
clgr:Imatinib
rdf:type
clgo:Cancer_treatment clgo:Pyridine clgo:Non-receptor_tyrosine_kinase_inhibitor clgo:Orphan_drug clgo:Benzanilide clgo:Antileukemic_drug clgo:World_Health_Organization_essential_medicine clgo:Aminopyrimidine clgo:Disease clgo:Antineoplastic_agent clgo:Largest_selling_pharmaceutical_product clgo:Piperazine owl:NamedIndividual clgo:Chemotherapeutic_agent clgo:Novartis_brand
rdfs:label
Imatinib
owl:sameAs
dbr:Imatinib
prov:wasDerivedFrom
n4:Dasatinib n5:Piperazines n4:CYP3A4 n4:Receptor_tyrosine_kinase n5:Benzanilides n4:List_of_chemotherapeutic_agents n4:Scleroderma n5:World_Health_Organization_essential_medicines n4:Piperazine n4:WHO_Model_List_of_Essential_Medicines_for_Children n4:List_of_antineoplastic_agents n5:Novartis_brands n4:Protein_kinase_inhibitor n4:Nanjing_Ange_Pharmaceutical n4:Eosinophil n4:Targeted_therapy n4:Mastocytosis n5:Non-receptor_tyrosine_kinase_inhibitors n4:List_of_antileukemic_drugs n4:WHO_Model_List_of_Essential_Medicines n5:Pyridines n4:Hypopigmentation n5:Cancer_treatments n5:Orphan_drugs n4:Timeline_of_cancer_treatment_development n4:Benzylpiperazine n11:In n4:Personalized_medicine n5:Aminopyrimidines n4:List_of_largest_selling_pharmaceutical_products n12:Farber_Cancer_Institute n13:drug_interactions n4:Novartis
skos:prefLabel
Imatinib
skos:altLabel
Imantinib STI571 Gleevec imatinib mesylate imatinib Gleevec (Imatinib) Imatinib mesylate Glivec imatinib therapy diseases
clgo:alternativeName
Gleevec, Glivec, others
clgo:bioavailability
98.0
clgo:casNumber
152459-95-5 (mesilate)
clgo:chEBI
45783
clgo:chEMBL
941
clgo:class
clgr:Tyrosine_kinase_inhibitor
clgo:drugbank
DB00619
clgo:fdaUniiCode
BKJ8M8G5HI
clgo:kegg
D08066
clgo:medlinePlus
a606018
clgo:pubchem
5291
Subject Item
clgr:Brian_Druker
clgo:knownFor
clgr:Imatinib